Results 161 to 170 of about 84,630 (262)

Cryo-EM structures of DrNKCC1 and hKCC1: a new milestone in the physiology of cation-chloride cotransporters [PDF]

, 2019
Eric Delpire, Jiangtao Guo
openalex   +1 more source

Real-World Data: Critical Evidence to Better Understanding Kidney Benefits with Sodium-Glucose Cotransporter 2 Inhibitors. [PDF]

Kidney360
Neumiller JJ, Tuttle KR.
europepmc   +1 more source

Beneficial effect of sodium-glucose cotransporter 2 inhibitors on kidney function can be just a mirage. [PDF]

World J Nephrol
Adeva-Andany MM.
europepmc   +1 more source

Sodium-Glucose Cotransporter 2 Inhibitors in Diabetic Solid Organ Transplant Recipients: A Systematic Review and Meta-Analysis of Comparative Studies. [PDF]

J Diabetes Res
Geum MJ, Oh KS, Ah YM.
europepmc   +1 more source

Rekombinante Expression und Identifizierung essentieller Strukturelemente des humanen H+-Aminosäure-Cotransporters hPAT1

, 2009
Madlen Dorn
openalex   +1 more source

SGLT-2 Inhibitors for the Treatment of Hyperkalemia in Children With Kidney Disease and Heart Failure Receiving Renin-Angiotensin-Aldosterone Inhibition: A Call for Data. [PDF]

J Pediatr Pharmacol Ther
Assadi F, Bidabadi E.
europepmc   +1 more source

Elective peri‐operative management of adults taking glucagon‐like peptide‐1 receptor agonists, glucose‐dependent insulinotropic peptide agonists and sodium‐glucose cotransporter‐2 inhibitors: a multidisciplinary consensus statement [PDF]

Kariem El‐Boghdadly, Jugdeep Dhesi, Philippa Fabb, Nicholas Levy, Dileep N. Lobo, Andrew McKechnie, Омар Мустафа, Philip Newland‐Jones, Anil Patel, Dimitri J. Pournaras, Ken Clare, Ketan Dhatariya   +11 more
openalex   +1 more source

Corrigendum to “Diuretic effects of sodium–glucose cotransporter 2 inhibitor in patients with type 2 diabetes mellitus and heart failure” [Int. J. Cardiol. 201 (Jul 31 2015) 1–3] [PDF]

, 2015
Tetsushiro Takeuchi, Kaoru Dohi, Taku Omori, Keishi Moriwaki, Yuichi Sato, Shiro Nakamori, Naoki Fujimoto, Eitaro Fujii, Norikazu Yamada, Masaaki Ito   +9 more
openalex   +1 more source

Favorable outcomes of SGLT2 inhibitor use in pacemaker recipients: a population-based study. [PDF]

Cardiovasc Diabetol
Avidan Y, Danon A, Hadar D, Aker A, Yahav A, Caspi O, Kassem S.   +6 more
europepmc   +1 more source

Reversible complete left bundle branch block and a wide QRS complex following administration of sodium-glucose cotransporter-2 inhibitor and volume reduction in a patient with systolic heart failure: a case report

Masaki Takenaka, Satoshi Yanagisawa, Yukihiko Yoshida, Yasuya Inden, Toyoaki Murohara   +4 more
openalex   +1 more source